Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schistosoma mansoni | 36 | 2023 | 36 | 7.590 |
Why?
|
| NADH, NADPH Oxidoreductases | 12 | 2023 | 12 | 2.130 |
Why?
|
| Schistosomicides | 7 | 2023 | 7 | 2.120 |
Why?
|
| Multienzyme Complexes | 11 | 2021 | 23 | 2.070 |
Why?
|
| Helminth Proteins | 10 | 2015 | 12 | 1.750 |
Why?
|
| Schistosomiasis mansoni | 11 | 2018 | 11 | 1.730 |
Why?
|
| Enzyme Inhibitors | 8 | 2020 | 110 | 1.530 |
Why?
|
| Animals | 46 | 2023 | 3427 | 1.440 |
Why?
|
| Schistosomiasis | 4 | 2023 | 4 | 1.220 |
Why?
|
| Aminoacyltransferases | 3 | 2013 | 3 | 1.220 |
Why?
|
| Anthelmintics | 6 | 2020 | 8 | 1.050 |
Why?
|
| Gene Expression Profiling | 7 | 2013 | 133 | 1.010 |
Why?
|
| Molecular Sequence Data | 18 | 2013 | 186 | 0.880 |
Why?
|
| Oxidation-Reduction | 11 | 2023 | 60 | 0.850 |
Why?
|
| Peroxiredoxins | 10 | 2021 | 11 | 0.780 |
Why?
|
| Amino Acid Sequence | 15 | 2013 | 147 | 0.750 |
Why?
|
| Peroxidases | 4 | 2006 | 7 | 0.710 |
Why?
|
| Ancylostoma | 3 | 2019 | 3 | 0.700 |
Why?
|
| Mice | 15 | 2023 | 1298 | 0.700 |
Why?
|
| Recombinant Proteins | 12 | 2013 | 167 | 0.700 |
Why?
|
| Thioredoxin-Disulfide Reductase | 7 | 2023 | 7 | 0.650 |
Why?
|
| Antigens, Helminth | 4 | 2007 | 4 | 0.550 |
Why?
|
| Auranofin | 6 | 2022 | 6 | 0.550 |
Why?
|
| Phytochelatins | 2 | 2013 | 2 | 0.540 |
Why?
|
| Albumins | 2 | 2006 | 17 | 0.520 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 2 | 0.510 |
Why?
|
| Gene Expression | 3 | 2013 | 186 | 0.450 |
Why?
|
| Geranyltranstransferase | 1 | 2013 | 1 | 0.440 |
Why?
|
| Diphosphonates | 1 | 2013 | 19 | 0.430 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2013 | 35 | 0.420 |
Why?
|
| Ovum | 2 | 2015 | 2 | 0.410 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 96 | 0.400 |
Why?
|
| Cloning, Molecular | 7 | 2011 | 28 | 0.400 |
Why?
|
| Thioredoxins | 5 | 2023 | 7 | 0.380 |
Why?
|
| Oxadiazoles | 2 | 2009 | 7 | 0.380 |
Why?
|
| NADP | 3 | 2023 | 7 | 0.370 |
Why?
|
| Biocatalysis | 1 | 2011 | 1 | 0.370 |
Why?
|
| Neoplasm Proteins | 2 | 2002 | 52 | 0.370 |
Why?
|
| Models, Molecular | 7 | 2018 | 80 | 0.360 |
Why?
|
| Drug Design | 3 | 2008 | 21 | 0.350 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 149 | 0.340 |
Why?
|
| Glutathione | 5 | 2023 | 20 | 0.340 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 4 | 0.340 |
Why?
|
| Life Cycle Stages | 2 | 2007 | 4 | 0.330 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 5 | 0.330 |
Why?
|
| Oxidative Stress | 2 | 2006 | 89 | 0.320 |
Why?
|
| Female | 15 | 2015 | 14160 | 0.300 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2020 | 6 | 0.300 |
Why?
|
| B-Lymphocytes | 4 | 2005 | 50 | 0.300 |
Why?
|
| Glutathione Reductase | 3 | 2023 | 4 | 0.290 |
Why?
|
| Sequence Alignment | 5 | 2009 | 16 | 0.280 |
Why?
|
| Male | 12 | 2015 | 13813 | 0.280 |
Why?
|
| Proteome | 1 | 2007 | 38 | 0.270 |
Why?
|
| Kinetics | 5 | 2013 | 186 | 0.270 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 33 | 0.270 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2006 | 3 | 0.270 |
Why?
|
| DNA, Helminth | 5 | 2013 | 5 | 0.260 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2019 | 24 | 0.260 |
Why?
|
| Disulfides | 2 | 2023 | 9 | 0.250 |
Why?
|
| Biomphalaria | 3 | 2009 | 3 | 0.230 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 79 | 0.230 |
Why?
|
| Brugia malayi | 2 | 2022 | 2 | 0.230 |
Why?
|
| Onchocerca volvulus | 2 | 2022 | 2 | 0.230 |
Why?
|
| Drug Discovery | 3 | 2020 | 13 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 251 | 0.220 |
Why?
|
| Proteins | 2 | 2021 | 63 | 0.220 |
Why?
|
| Open Reading Frames | 2 | 2015 | 9 | 0.220 |
Why?
|
| Drug Resistance | 2 | 2015 | 46 | 0.220 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 8 | 0.210 |
Why?
|
| Phylogeny | 5 | 2012 | 46 | 0.210 |
Why?
|
| Escherichia coli | 3 | 2013 | 47 | 0.210 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 1 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 5 | 2013 | 56 | 0.210 |
Why?
|
| Adenylosuccinate Lyase | 1 | 2002 | 1 | 0.210 |
Why?
|
| Oxidoreductases | 1 | 2002 | 9 | 0.200 |
Why?
|
| Parasites | 1 | 2022 | 1 | 0.200 |
Why?
|
| Antiparasitic Agents | 1 | 2021 | 1 | 0.190 |
Why?
|
| Humans | 17 | 2022 | 25165 | 0.180 |
Why?
|
| Hydrogen Peroxide | 4 | 2008 | 41 | 0.180 |
Why?
|
| Egg Proteins | 1 | 2001 | 1 | 0.180 |
Why?
|
| Praziquantel | 2 | 2023 | 3 | 0.180 |
Why?
|
| Nanostructures | 1 | 2021 | 10 | 0.180 |
Why?
|
| Gold | 1 | 2020 | 1 | 0.180 |
Why?
|
| Helminthiasis | 1 | 2020 | 1 | 0.180 |
Why?
|
| Protozoan Infections | 1 | 2020 | 1 | 0.180 |
Why?
|
| Antiprotozoal Agents | 1 | 2020 | 6 | 0.180 |
Why?
|
| Coordination Complexes | 1 | 2020 | 2 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 4 | 2007 | 385 | 0.170 |
Why?
|
| Expressed Sequence Tags | 3 | 2007 | 5 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 58 | 0.170 |
Why?
|
| Oviposition | 1 | 2019 | 2 | 0.160 |
Why?
|
| Crystallography, X-Ray | 5 | 2019 | 10 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 127 | 0.150 |
Why?
|
| Neoplasms | 1 | 2020 | 215 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2011 | 20 | 0.150 |
Why?
|
| Protein Conformation | 3 | 2013 | 70 | 0.140 |
Why?
|
| Selenocysteine | 2 | 2011 | 2 | 0.140 |
Why?
|
| Base Sequence | 4 | 2006 | 104 | 0.140 |
Why?
|
| Computational Biology | 3 | 2012 | 20 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2011 | 293 | 0.130 |
Why?
|
| Solubility | 2 | 2013 | 22 | 0.130 |
Why?
|
| Substrate Specificity | 2 | 2013 | 20 | 0.130 |
Why?
|
| Introns | 3 | 2009 | 16 | 0.130 |
Why?
|
| Onchocerciasis | 1 | 2015 | 1 | 0.120 |
Why?
|
| Microfilariae | 1 | 2015 | 2 | 0.120 |
Why?
|
| Elephantiasis, Filarial | 1 | 2015 | 2 | 0.120 |
Why?
|
| Loiasis | 1 | 2015 | 2 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2007 | 27 | 0.110 |
Why?
|
| Mice, Inbred C3H | 3 | 2007 | 18 | 0.110 |
Why?
|
| Gene Library | 2 | 2007 | 8 | 0.110 |
Why?
|
| Ancylostomiasis | 1 | 2013 | 1 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2013 | 2 | 0.110 |
Why?
|
| Genome, Helminth | 2 | 2012 | 2 | 0.110 |
Why?
|
| Retroelements | 2 | 2003 | 3 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Xenobiotics | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hydrolases | 1 | 2013 | 4 | 0.100 |
Why?
|
| Zygote | 1 | 2012 | 1 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 98 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 4 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2002 | 23 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2012 | 43 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2003 | 141 | 0.100 |
Why?
|
| Precipitin Tests | 2 | 2002 | 11 | 0.100 |
Why?
|
| Metals | 1 | 2013 | 135 | 0.090 |
Why?
|
| Cluster Analysis | 2 | 2012 | 44 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 17 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 12 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2011 | 21 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 342 | 0.090 |
Why?
|
| Host-Parasite Interactions | 2 | 2009 | 2 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2008 | 401 | 0.090 |
Why?
|
| Methionine | 1 | 2009 | 1 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 32 | 0.080 |
Why?
|
| Reactive Oxygen Species | 2 | 2008 | 110 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2008 | 95 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2009 | 77 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2008 | 20 | 0.080 |
Why?
|
| Catalysis | 2 | 2009 | 16 | 0.080 |
Why?
|
| Fasciola hepatica | 1 | 2008 | 1 | 0.080 |
Why?
|
| Fascioliasis | 1 | 2008 | 1 | 0.080 |
Why?
|
| Macrophage Activation | 1 | 2008 | 9 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2008 | 17 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 82 | 0.080 |
Why?
|
| Schistosoma | 2 | 2023 | 2 | 0.070 |
Why?
|
| Nitric Oxide Donors | 1 | 2008 | 5 | 0.070 |
Why?
|
| Genes, Helminth | 2 | 2009 | 2 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 2005 | 20 | 0.070 |
Why?
|
| Amides | 1 | 2008 | 11 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 118 | 0.070 |
Why?
|
| Macrophages | 1 | 2008 | 87 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 319 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 2 | 2009 | 2 | 0.070 |
Why?
|
| Exons | 2 | 2009 | 30 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 13 | 0.070 |
Why?
|
| Naphthoquinones | 1 | 2007 | 2 | 0.070 |
Why?
|
| Disease Vectors | 1 | 2007 | 1 | 0.070 |
Why?
|
| RNA, Helminth | 1 | 2007 | 1 | 0.070 |
Why?
|
| Sex Differentiation | 1 | 2007 | 2 | 0.070 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2007 | 8 | 0.070 |
Why?
|
| Genes, Homeobox | 1 | 2007 | 5 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 34 | 0.070 |
Why?
|
| Cysteine | 2 | 2022 | 7 | 0.070 |
Why?
|
| RNA Interference | 1 | 2007 | 35 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 38 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 29 | 0.070 |
Why?
|
| Markov Chains | 1 | 2006 | 32 | 0.070 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 4 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 6 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2007 | 148 | 0.060 |
Why?
|
| Parasite Egg Count | 2 | 2003 | 2 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 430 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 61 | 0.060 |
Why?
|
| Terminal Repeat Sequences | 2 | 2002 | 3 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 1 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2005 | 5 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2002 | 32 | 0.060 |
Why?
|
| Epitopes | 1 | 2005 | 42 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 31 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2005 | 79 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 15 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 27 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2004 | 14 | 0.060 |
Why?
|
| Electrons | 1 | 2004 | 19 | 0.060 |
Why?
|
| Protein Binding | 1 | 2004 | 119 | 0.060 |
Why?
|
| Immune Sera | 1 | 2003 | 5 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 6 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 15 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 14 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 9 | 0.050 |
Why?
|
| Genome | 1 | 2003 | 10 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 113 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosoma haematobium | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosomiasis haematobia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2003 | 13 | 0.050 |
Why?
|
| Peroxiredoxin III | 1 | 2002 | 1 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 3 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 77 | 0.050 |
Why?
|
| Glutaredoxins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Selenoproteins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Models, Biological | 1 | 2004 | 313 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 24 | 0.050 |
Why?
|
| Purines | 1 | 2002 | 42 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2002 | 112 | 0.050 |
Why?
|
| Biopolymers | 1 | 2021 | 6 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2020 | 20 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 2 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 1336 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 233 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 42 | 0.040 |
Why?
|
| Diethylcarbamazine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Filaricides | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gerbillinae | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ivermectin | 1 | 2015 | 1 | 0.030 |
Why?
|
| Loa | 1 | 2015 | 1 | 0.030 |
Why?
|
| Albendazole | 1 | 2015 | 3 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 8 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 4 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 567 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 251 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 13 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2013 | 15 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 34 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 15 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 12 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 14 | 0.020 |
Why?
|
| Selenium | 1 | 2009 | 10 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2009 | 9 | 0.020 |
Why?
|
| DNA | 1 | 2009 | 103 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 13 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 8 | 0.020 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2008 | 1 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2008 | 11 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2008 | 1 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 639 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2008 | 278 | 0.020 |
Why?
|
| Chromones | 1 | 2007 | 7 | 0.020 |
Why?
|
| Androstadienes | 1 | 2007 | 7 | 0.020 |
Why?
|
| Morpholines | 1 | 2007 | 11 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 479 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 97 | 0.020 |
Why?
|
| Apoptosis | 1 | 2007 | 193 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 162 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2007 | 91 | 0.020 |
Why?
|
| Genomic Library | 1 | 2003 | 1 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 3 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 34 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 7259 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 49 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 80 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2000 | 3 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 7 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 7 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 42 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 2018 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 8303 | 0.010 |
Why?
|